// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Co‐administration of FVIII with IVIG: Effect on Immune Response to FVIII in Hemophilia A Mice

S. Afraz - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

rFVIII

Comparison of Pharmacokinetic Parameters of Two Different Extended Half‐life factor VIII Concentrates in Hemophilia A (HA) Patients

J. Teitel - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

FVIII

Long‐term Safety and Efficacy of Nonacog Beta Pegol in Previously Treated Children with Haemophilia B, Treated for at Least 5 Years

M. Carcao - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Hemophilia

N/A

Public Health Policy Analysis of Clotting Factor Concentrate Procurement Policy in Canada

Z. Liederman - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The WFH World Bleeding Disorders Registry ‐ One Year Later

B. Konkle - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

N/A

Web‐based Application for the Population Pharmacokinetic Service (WAPPS)′s Impact on Dosage Selection: A Single Pediatric Centre Experience, Retrospective Review

C. Kwan - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

N/A

Aerobic Exercise and Desmopressin Additively Increase Factor VIII in Mild Hemophilia A ‐ Interim Results from a Randomized Study

R. Kumar - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

Desmopressin

Combining Data from Hemophilia Registries ‐ A Proof of Concept Study

D. Coffin - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

N/A

Real‐world Study of Physician Practice Patterns, Efficacy and Safety of Human Cell Line‐derived Recombinant Factor VIII in Adults with Hemophilia A

H. Sun - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

Recombinant Factor VIII

HaemoValue: Development of a Set of Outcomes for Measuring Value in Persons with Haemophilia

E. van Balen - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

N/A

Adding the Patient's Voice to a Hemophilia‐specific Goal Menu to Facilitate Goal Attainment Scaling: A Qualitative Study

J.C. Roberts - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

N/A

N/A

The First Chinese Hemophilia Individualized Prophylaxis Study (CHIPS): Improvement in Health‐related Quality of Life (HRQoL) CHO‐KLAT Scores in Boys with Severe Hemophilia A in China

R. Wu - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

FVIII

Development and Validation of a Population Pharmacokinetic Model for rAHF‐FL‐PEG (Adynovate): A Report on behalf of the WAPPS‐hemo Investigators ad hoc Subgroups

P. Chelle - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

N/A

Efficacy and Safety of Fibrinogen Concentrate for Treatment of Bleeding, Surgery or Routine Prophylaxis in Subjects with Congenital Fibrinogen Deficiency

J. Teitel - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Fibrinogen (IV)

Congenital Factor XIII Deficiency in Pediatric Patients in Kuwait: A Retrospective Chart Review

H. Mohammad - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

DELPHI Expert Consensus Statements on Clinical Evaluation of Bleeds in Patients with Acquired Haemophilia

A. Tiede - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

N/A

Von Willebrand Disease: An International Survey Assessing Important Topics for Decision‐making

M.A. Kalot - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Hemophilia

N/A

Reported Presentation, Treatment, Mutation Analysis and Outcome of Two Children with Atypical Hemolytic Uremic Syndrome

P. Pongphitcha - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Atypical hemolytic uremic syndrome

N/A

Validation of the Patient Reported Outcomes Burdens and Experiences (PROBE) Study Questionnaire

M. Skinner - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Identification of New Deep Intronic Variants Causing Hemophilia A by Whole F8 Gene Sequencing, mRNA Analysis and Functional Confirmation, in “Variant‐Negative” French and Canadian Patients

F. Lassalle - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

N/A

Copyright © 2026. QuantiNova All rights reserved